Login to Your Account

Focusing downstream may help untangle AD target woes

By Anette Breindl
Senior Science Editor

Tuesday, November 7, 2017

Treating aging rats with an experimental compound that prevented neuronal cell death protected the animals from both depressive symptoms that are often the first symptom of Alzheimer’s disease, and the memory decline that follows. The compound did not, however, affect the amyloid beta (a-beta) plaques, tau phosphorylation and inflammation.

To continue reading subscribe now to Science News

Learn More about Science News

Already a subscriber? Sign In or Buy now to activate your subscription